The Calcium-Phosphorus (Ca × P) product is a clinical calculation used to evaluate the risk of mineral deposition in soft tissues, particularly in patients with Chronic Kidney Disease (CKD). It is a key indicator in the management of Mineral and Bone Disorder (CKD-MBD), as elevated levels are strongly associated with vascular calcification and cardiovascular events.